ArticleFrontiers in pediatrics2026
Prediction of chronicity in pediatric immune thrombocytopenia based on developed and internally validated machine learning models.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The prediction of disease chronicity when immune thrombocytopenia is first diagnosed.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary immune thrombocytopenia (ITP) typically remits spontaneously, 20%-30% of children progress to chronic ITP. Early prediction of chronicity in ITP may facilitate in timely intervention and improve prognosis. Methods: In our current study, we collected clinical features such as platelet-specific antibodies and used machine learning (ML) to predict chronic progression of ITP. ML models were applied to data from our hospital. Model performance was evaluated using accuracy, precision, sensitivity, specificity, Results: A total of 156 patients were enrolled for ITP classification prediction model construction, including 68 chronic patients and 88 non-chronic patients. All models performed well, with AUC values ranging from 0.833 to 0.864. The ET model was selected for predictive model construction due to its highest AUROC score and interpretability. Then, the ET model identified occult disease course, age, and platelet-specific antibodies as significant predictors. The absence of an occult disease course decreased the probability of chronic ITP, while older age increased it. It's worth noting when platelet-specific antibodies are negative, patients are less likely to develop chronic ITP. Conclusions: In conclusion, the ET model achieved high prediction accuracy for ITP chronicity by using clinical parameters, especially platelet-specific antibodies. Despite the limited sample size, this study suggests occult disease course, age, and platelet-specific antibodies are early predictors of chronic ITP in children, meriting confirmed in future larger cohort multicenter study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.